Jazz Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Jazz Pharmaceuticals (Nasdaq: JAZZ) will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on January 10, 2022, from 2:15 – 2:55 p.m. ET. Bruce Cozadd, chairman and CEO, will lead the presentation. Interested parties can access a live audio webcast through the Investors section of Jazz Pharmaceuticals' website. A replay will be available for 30 days post-event. Jazz Pharmaceuticals is dedicated to developing transformative medicines for serious diseases and operates globally, serving patients in nearly 75 countries.

DUBLIN, Jan. 3, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced Bruce Cozadd, chairman and chief executive officer, will present virtually as part of the 40^th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022, from 2:15 – 2:55 p.m. ET / 7:15 – 7:55 p.m. GMT.  

A live audio webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharma.com. Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast. A replay of the webcast will be available on the website for 30 days.  

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules and biologics, and through innovative delivery technologies and cannabinoid science. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit www.jazzpharma.com and follow @JazzPharma on Twitter.

Contacts:

Investors:
Andrea N. Flynn, Ph.D.
Vice President, Head, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com      
Ireland, +353 1 634 3211
U.S., +1 650 496 2717

Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
Ireland, +353 1 697 2141
U.S., +1 215 867 4948

View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-present-at-the-40th-annual-jp-morgan-healthcare-conference-301452971.html

SOURCE Jazz Pharmaceuticals plc

FAQ

What date will Jazz Pharmaceuticals present at the J.P. Morgan Healthcare Conference?

Jazz Pharmaceuticals will present on January 10, 2022.

Who is presenting for Jazz Pharmaceuticals at the conference?

Bruce Cozadd, the chairman and CEO, will present for Jazz Pharmaceuticals.

How can I access the live webcast of Jazz Pharmaceuticals' presentation?

The live audio webcast can be accessed from the Investors section of Jazz Pharmaceuticals' website.

Is there a replay available for Jazz Pharmaceuticals' presentation?

Yes, a replay will be available on the website for 30 days after the presentation.

What is the purpose of Jazz Pharmaceuticals as a company?

Jazz Pharmaceuticals aims to innovate and transform the lives of patients with serious diseases.